We are live on ! Find out more
CIA

Capital Impact Advisors Portfolio holdings

AUM $247M
1-Year Est. Return 31.15%
This Fund
S&P 500
This Quarter Est. Return
+11.75%
1 Year Est. Return
+31.15%
3 Year Est. Return
5 Year Est. Return
10 Year Est. Return
AUM
$90.9M
AUM Growth
+$9.39M
Cap. Flow
+$2.51M
Cap. Flow %
2.76%
Top 10 Hldgs %
11.75%
Holding
179
New
2
Increased
99
Reduced
24
Closed
5

Top Buys

Rank Stock Value
1
UTHR icon
United Therapeutics
UTHR
+$777K
2
MTCH icon
Match Group
MTCH
+$705K
3
CLH icon
Clean Harbors
CLH
+$478K
4
ARVN icon
Arvinas
ARVN
+$443K
5
CHEF icon
Chefs' Warehouse
CHEF
+$406K

Sector Composition

Rank Sector Weight
1 Healthcare 31.93%
2 Technology 22.89%
3 Consumer Discretionary 12.96%
4 Industrials 10%
5 Financials 5.74%
Name Market Value Portfolio Weight Shares or Principal Change
in Stake
Capital Flow
TDOC icon
126
Teladoc Health
TDOC
$1.66B
$326K 0.36%
12,881
+969
+8% +$24.4K
NTRA icon
127
Natera
NTRA
$36.4B
$320K 0.35%
6,582
+447
+7% +$22.8K
CERS icon
128
Cerus
CERS
$575M
$318K 0.35%
129,404
+8,489
+7% +$20.2K
P
129
Everpure Inc
P
$23B
$317K 0.35%
8,605
+1,959
+29% +$55.5K
GTLB icon
130
GitLab
GTLB
$5.75B
$317K 0.35%
6,194
+715
+13% +$26.6K
INTA icon
131
Intapp
INTA
$2.44B
$316K 0.35%
7,551
-6,997
-48% -$302K
PNFP icon
132
Pinnacle Financial Partners Inc
PNFP
$15.8B
$315K 0.35%
5,556
PACB icon
133
Pacific Biosciences
PACB
$435M
$314K 0.34%
23,575
IMAX icon
134
IMAX
IMAX
$2.67B
$311K 0.34%
18,330
+1,312
+8% +$24.9K
KOD icon
135
Kodiak Sciences
KOD
$2.5B
$310K 0.34%
44,926
ALEC icon
136
Alector
ALEC
$169M
$309K 0.34%
51,465
FIVE icon
137
Five Below
FIVE
$11.6B
$308K 0.34%
1,565
+149
+11% +$29.1K
RLAY icon
138
Relay Therapeutics
RLAY
$4B
$303K 0.33%
24,117
+1,505
+7% +$18.7K
SLP icon
139
Simulations Plus
SLP
$371M
$303K 0.33%
6,983
+564
+9% +$24.7K
CNXN icon
140
PC Connection
CNXN
$2.09B
$302K 0.33%
6,691
LAND
141
Gladstone Land Corp
LAND
$365M
$299K 0.33%
18,397
HLI icon
142
Houlihan Lokey
HLI
$9.72B
$285K 0.31%
2,901
DOMO icon
143
Domo
DOMO
$171M
$284K 0.31%
19,357
+1,805
+10% +$26.7K
MC icon
144
Moelis & Co
MC
$4.85B
$276K 0.3%
6,092
-1,780
-23% -$71K
DKNG icon
145
DraftKings
DKNG
$12.2B
$272K 0.3%
10,245
+2,367
+30% +$54.5K
WOLF icon
146
Wolfspeed
WOLF
$1.04B
$269K 0.3%
4,835
+2,228
+85% +$114K
THO icon
147
Thor Industries
THO
$4.06B
$269K 0.3%
2,596
+331
+15% +$28K
SPT icon
148
Sprout Social
SPT
$530M
$262K 0.29%
5,668
-3,748
-40% -$178K
TASK icon
149
TaskUs
TASK
$594M
$249K 0.27%
22,006
+4,292
+24% +$52.2K
TFIN icon
150
Triumph Financial Inc
TFIN
$1.81B
$246K 0.27%
4,053

Similar funds

Capital Impact Advisors's Q2 2023 Portfolio in Review

As of Q2 2023, Capital Impact Advisors held 179 positions worth $90.9M, up 12% from $81.5M the previous quarter. Its ten largest holdings account for 12% of the portfolio.

Trading was light in Q2 2023: portfolio turnover was 3.9%. Capital Impact Advisors opened 2 new positions and exited 5, leaving the 179-position portfolio largely intact.

By sector, the portfolio is most concentrated in Healthcare at 32% of assets, up from 31% a quarter earlier, followed by Technology and Consumer Discretionary.

  • Capital Impact Advisors's largest Q2 2023 buy was United Therapeutics: 3,507 shares worth $774K.
  • Capital Impact Advisors added most to Match Group in Q2 2023, an estimated $705K increase.
  • Capital Impact Advisors's biggest Q2 2023 reduction was Super Micro Computer, cutting an estimated $760K.
  • Capital Impact Advisors fully exited Kinder Morgan in Q2 2023, selling an estimated $521K.
  • Capital Impact Advisors's ten largest holdings make up 12% of its $90.9M portfolio in Q2 2023.
  • Capital Impact Advisors opened 2 new positions and closed 5 in Q2 2023.
  • Capital Impact Advisors's portfolio value rose 12% quarter-over-quarter to $90.9M.

Based on Capital Impact Advisors's 13F filing for Q2 2023, filed 14 Aug 2023.